Health In Tech Q2 2026 Earnings Call: $32.3M Contracted Revenue, $66.3M Pipeline, Reaffirms $45-50M Guidance
HIT sits 20% above its 52-week low of $0.85.
Summary
Health In Tech's Q2 2026 earnings call revealed $32.3M in contracted revenue and a $66.3M pipeline, reframing a GAAP revenue decline as a timing shift and reaffirming full-year guidance of $45-50M.
Key Events · Earnings and Guidance · HIT
-
Q2 Revenue Declines on Carrier Onboarding Timing
GAAP revenue fell 13.5% to $8.1M from $9.3M a year ago, which management attributes to a new carrier onboarding that shifted policy effective dates into future quarters, not a demand problem.
-
New Forward Metrics: $32.3M Contracted, $66.3M Pipeline
Contracted revenue totaled $32.3M for H1 2026, with $14.0M expected in H2 2026 and $1.0M in 2027. Pipeline revenue stood at $66.3M as of July 31, 2026, with $1.9M contracted and the remaining $64.4M at an expected 15-40% conversion rate.
-
Full-Year Guidance Reaffirmed at $45-50M
Management reaffirmed 2026 revenue guidance of $45M to $50M, citing contracted and pipeline revenue as providing real forward visibility.
-
Distribution Network Grows 19.9% to 933 Partners
The company ended Q2 with 933 brokers, TPAs, and agencies, up from 778 a year ago, driven by a capital-light, partner-driven model.
Analysis · HIT · Finance
Health In Tech's Q2 2026 earnings call transcript provides new forward-looking metrics that reframe the revenue decline. The company reported a GAAP revenue drop to $8.1M from $9.3M, but management attributes this to a carrier onboarding timing shift, not demand weakness. The key new disclosures are $32.3M in contracted revenue for H1 2026 and a $66.3M pipeline as of July 31, 2026, which management argues are better indicators of future revenue than the lagging GAAP figure. The company reaffirmed full-year 2026 revenue guidance of $45-50M. Distribution partners grew 19.9% YoY to 933, and the first employer group was secured under the Three-Year Rate Stabilization Program. The balance sheet shows $6.5M in cash and $11.8M in working capital. While the net loss of $2.5M and negative adjusted EBITDA of $1.3M reflect continued investment, the new contracted and pipeline metrics provide visibility into future revenue that was not previously disclosed.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HIT was trading at $1.02 on NASDAQ in the Finance sector, with a market capitalization of approximately $69.5M. The 52-week trading range was $0.85 to $4.02. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.